Advancing Healthcare Equity in Resource-Limited Settings: Evidence from Clinical Research, Diagnostic Innovation and Community-Based Healthcare

1. Introduction

Access to timely and appropriate healthcare is an essential component of population health. However, healthcare inequalities persist across geographical and socioeconomic groups, particularly in rural and tribal regions. Limited diagnostic facilities, shortages of trained healthcare personnel and difficulties accessing specialist services may contribute to delayed diagnosis and treatment.

In India, healthcare equity requires attention to both disease-specific interventions and the broader health systems responsible for delivering these services. Research examining molecular mechanisms, clinical conditions, diagnostic technologies and community-level interventions can provide evidence for improving healthcare delivery.

Publications across different biomedical disciplines offer an opportunity to understand these challenges from multiple perspectives. Their relevance extends from fundamental biological research to clinical management and population-level health interventions.

2. Scientific Research as a Foundation for Better Healthcare

Fundamental biological research contributes to the understanding of cellular responses, biological defence mechanisms and disease-associated pathways. Investigations involving Arabidopsis thaliana have examined salicylic acid accumulation, jasmonic acid signalling, pathogen defence and immune regulation [1, 2, 3, 4, 5, 6, 7, 8, 10]. Research involving myostatin has also explored mechanisms associated with skeletal muscle physiology [28].

Although these studies address different biological systems, they demonstrate the importance of experimental investigations in generating fundamental scientific knowledge. Translating such discoveries into healthcare applications requires additional disease-specific research and clinical validation.

Research into ferroptosis-associated mechanisms in cancer provides another example of how fundamental biological processes may inform future therapeutic investigations [37].

3. Diagnostic Accessibility in Underserved Populations

Access to diagnostic services is a major determinant of healthcare equity. Delays in identifying diseases can affect treatment opportunities and increase the burden on patients and healthcare facilities.

Research on point-of-care testing for sickle cell disease in tribal regions has investigated the feasibility of decentralised diagnostic approaches [13]. The role of primary healthcare providers in sickle cell disease management has also been examined, particularly in relation to diagnosis and continuing care [15].

Further research has explored barriers faced by patients with sickle cell disease and their caregivers when accessing healthcare services [25]. Nanotechnology-based approaches for detecting sickle cell disease and thalassemia represent another emerging diagnostic research area [27].

Laboratory research investigating serum stability for dengue diagnosis by ELISA also highlights the importance of specimen quality and appropriate diagnostic procedures [26].

These investigations demonstrate that diagnostic accessibility requires more than the availability of sophisticated technologies. Affordability, trained personnel, specimen management and integration with existing healthcare services are equally important.

4. Cancer Screening and Community Participation

Cancer screening programmes require effective coordination between healthcare institutions, frontline workers and communities.

Research examining oral potentially malignant disorders in western Rajasthan has provided regional epidemiological evidence relevant to oral cancer prevention [9]. Community health officer capacity-building initiatives in Jodhpur have explored approaches to strengthen oral cancer screening and early diagnosis [11].

Molecular docking investigations involving pyocyanin from Pseudomonas aeruginosa have explored possible molecular interactions relevant to oral cancer-associated pathways, although these findings require further experimental validation [19].

At the health-system level, research has examined community and healthcare barriers affecting oral cancer screening in India [20]. Similar investigations involving oral, breast and cervical cancer screening have examined factors influencing screening participation and implementation [22].

These studies indicate that improving cancer screening requires attention to community awareness, healthcare accessibility, referral pathways and the capacity of frontline healthcare professionals.

5. Addressing Infectious Diseases Through Integrated Care

Infectious disease control is closely associated with the availability of diagnostic services, continuity of treatment and the management of associated health conditions.

Research examining implementation challenges associated with National Tuberculosis Elimination Programme guidelines at Nutrition Rehabilitation Centres has explored health-system difficulties affecting programme delivery [12]. Studies involving malnourished children have investigated factors associated with pulmonary tuberculosis in rehabilitation-centre settings [16].

The relationship between tuberculosis and diabetes has been examined among notified patients in Jaipur [17]. Additional research has explored treatment outcomes and healthcare-seeking patterns among patients with tuberculosis-HIV comorbidity [18].

Healthcare provider perspectives on tuberculosis programme implementation and community-based research on tuberculosis-associated vulnerabilities in rural Jaipur provide further evidence about the influence of healthcare delivery and social determinants [23, 24].

Integrated services involving nutritional assessment, disease screening, appropriate referral and follow-up are particularly relevant to improving care among vulnerable populations.

6. Improving Clinical Care and Treatment Accessibility

Healthcare equity also involves ensuring that patients have access to appropriate clinical management across different medical specialties.

Research on benign breast diseases has examined the clinical spectrum and presentation of breast-related conditions [29]. Investigations into robotic surgery have discussed the potential contribution of artificial intelligence to surgical precision and personalised procedures [30].

Clinical studies evaluating pregabalin for postoperative pain management have explored approaches to improving perioperative care [31, 38]. Other publications have discussed uncommon musculoskeletal presentations, including Andersson lesions associated with ankylosing spondylitis [32], and the possible relationship between thyroid disorders and epilepsy [33].

Research on systemic light-chain amyloidosis has examined evolving diagnostic and therapeutic approaches [34]. These clinical investigations reflect the importance of improving disease recognition and treatment planning across different levels of healthcare.

7. Strengthening Primary Healthcare and Regional Infrastructure

Primary healthcare facilities play an important role in providing accessible and continuous health services. Their effectiveness depends on adequate staffing, infrastructure, essential diagnostic facilities and functional referral systems.

Facility-based research examining Health and Wellness Centres and Ayushman Arogya Mandirs in Jodhpur has explored aspects of healthcare delivery at the district level [14].

Bibliometric research on implementation science has examined global and Indian research developments, providing a broader understanding of research activity in this field [21].

The need for greater regional research capacity in Southern Rajasthan has also been discussed in publications proposing an ICMR research centre for Udaipur, Salumbar and Pratapgarh [35, 36]. Strengthening regional research institutions may support locally relevant investigations, clinical collaborations and evidence generation.

8. Future Directions

Future research should prioritise healthcare interventions that are practical, affordable and suitable for resource-limited settings. Diagnostic technologies should be assessed not only for analytical performance but also for feasibility under routine healthcare conditions.

Multicentre studies involving rural, urban and tribal populations could provide better evidence regarding differences in disease burden and healthcare accessibility. Greater collaboration between clinicians, epidemiologists, laboratory researchers and public health professionals may also improve the translation of research findings.

Particular attention should be given to training frontline healthcare workers, strengthening primary healthcare facilities and improving referral and follow-up mechanisms. Research institutions should also develop regional priorities based on local disease patterns and the needs of underserved populations.

9. Conclusion

Improving healthcare equity requires an integrated approach combining scientific research, clinical evidence and effective healthcare delivery. Investigations across molecular biology, diagnostic innovation, cancer screening, infectious disease management and clinical medicine provide different perspectives on existing healthcare challenges. However, their benefits depend on appropriate implementation, accessible services and adequate institutional capacity. Strengthening community-based interventions and regional research infrastructure may contribute to more equitable and evidence-informed healthcare delivery in India.

REFERENCES

1. Giri MK, Swain S, Gautam JK, Singh S, Singh N, Bhattacharjee L, et al. The Arabidopsis thaliana At4g13040 gene, a unique member of the AP2/EREBP family, is a positive regulator for salicylic acid accumulation and basal defense against bacterial pathogens. J Plant Physiol. 2014;171(10):860-867. doi:10.1016/j.jplph.2013.12.015. ↩
2. Gautam JK, Giri MK, Singh D, Chattopadhyay S, Nandi AK. MYC2 influences salicylic acid biosynthesis and defense against bacterial pathogens in Arabidopsis thaliana. Physiol Plant. 2021;173(4):2248-2261. doi:10.1111/ppl.13575. ↩
3. Giri MK, Gautam JK, Rajendra Prasad VB, Chattopadhyay S, Nandi AK. Rice MYC2 (OsMYC2) modulates light-dependent seedling phenotype, disease defence but not ABA signalling. J Biosci. 2017;42(3):501-508. doi:10.1007/s12038-017-9703-8. ↩
4. Singh V, Singh D, Gautam JK, Nandi AK. RSI1/FLD is a positive regulator for defense against necrotrophic pathogens. Physiol Mol Plant Pathol. 2019;107:40-45. doi:10.1016/j.pmpp.2019.04.005. ↩
5. Gautam JK, Nandi AK. APD1, the unique member of Arabidopsis AP2 family influences systemic acquired resistance and ethylene-jasmonic acid signaling. Plant Physiol Biochem. 2018;133:92-99. doi:10.1016/j.plaphy.2018.10.026. ↩
6. Mittal D, Gautam JK, Varma M, Laie A, Mishra S, Behera S, et al. External jasmonic acid isoleucine mediates amplification of plant elicitor peptide receptor (PEPR) and jasmonate-based immune signalling. Plant Cell Environ. 2024;47(4):1397-1415. doi:10.1111/pce.14812. ↩
7. Bhattacharjee L, Singh D, Gautam JK, Nandi AK. Arabidopsis thaliana serpins AtSRP4 and AtSRP5 negatively regulate stress-induced cell death and effector-triggered immunity induced by bacterial effector AvrRpt2. Physiol Plant. 2017;159(3):329-339. doi:10.1111/ppl.12516. ↩
8. Singh D, Patil V, Kumar R, Gautam JK, Singh V, Nandi AK. RSI1/FLD and its epigenetic target RRTF1 are essential for the retention of infection memory in Arabidopsis thaliana. Plant J. 2023;115(3):662-677. doi:10.1111/tpj.16252. ↩
9. Gautam JK, Mohanty SS, Babu BV. Prevalence and determinants of oral potentially malignant disorders in western Rajasthan. Sci Rep. 2025;15(1):15611. doi:10.1038/s41598-025-98096-8. ↩
10. Nishad A, Gautam JK, Agarwal I, Nandi AK. Immune priming promotes thermotolerance, whereas thermopriming suppresses systemic acquired resistance in Arabidopsis. Plant Cell Environ. 2025;48(5):3352-3363. doi:10.1111/pce.15364. ↩
11. Gautam JK, Anand PK, Chouhan M, Babu BV. Capacity building of community health officers for optimizing the screening and early diagnosis of oral cancer in Jodhpur, Rajasthan, India. Sci Rep. 2025;15(1):16027. doi:10.1038/s41598-025-00225-w. ↩
12. Anand PK, Patel D, Dewasi G, Gautam JK. Challenges and barriers in implementation of National Tuberculosis Elimination Program guidelines at Nutrition Rehabilitation Centers in India: a systematic review. J Epidemiol Glob Health. 2026;16(1):121. doi:10.1007/s44197-026-00538-7. ↩
13. Thakor M, Gautam JK, Panigrahi A, Garasiya D, Brhamnia SL, Mohanty SS. Operational feasibility of point-of-care testing for sickle cell disease in resource-limited settings of tribal sub-plan region of India. Diagnostics (Basel). 2025;15(3):348. doi:10.3390/diagnostics15030348. ↩
14. Gautam JK, Dewasi G, Khan A, Bhardwaj P. Assessment of Health and Wellness Centres/Ayushman Arogya Mandir in Jodhpur District, Rajasthan, India: a facility-based cross-sectional study [Preprint]. Research Square; 2026 Jun 24. doi:10.21203/rs.3.rs-9933554/v1. ↩
15. Gazta P, Gautam J, Thakor M, Bhardwaj P, Mohanty SS. Role of the primary healthcare providers in sickle cell disease management: a scoping review. J Community Genet. 2026;17(2):35. doi:10.1007/s12687-026-00867-x. ↩
16. Anand PK, Patel D, Lata S, Gautam JK, Chaudhary M, Singh M, et al. Factors associated with pulmonary TB in malnourished children admitted to rehabilitation centres. Int J Tuberc Lung Dis. 2026;30(1):21-26. doi:10.5588/ijtld.25.0338. ↩
17. Gautam JK, Thanvi A, Soni P, Anand PK. Estimation of the proportion and determinants of diabetes mellitus among notified tuberculosis patients in Jaipur, Rajasthan, India. Cureus. 2025;17(3). doi:10.7759/cureus.80319. ↩
18. Anand PK, Kumari R, Gautam JK. Disparities in healthcare seeking and treatment outcomes among tuberculosis-human immunodeficiency virus comorbidity cases: a case series from Jaipur, Rajasthan, India. J Public Health Prim Care. 2026;7(1):77-80. doi:10.4103/jphpc.jphpc_34_25. ↩
19. Choudhary S, Kumar P, Mohanty SS, Anand PK, Gautam JK. Molecular docking of pyocyanin from Pseudomonas aeruginosa with NADPH oxidase and Toll-like receptor 4: exploring the link between oral microbiome and oral cancer pathogenesis [Preprint]. bioRxiv; 2025 Aug 27. doi:10.1101/2025.08.24.671957. ↩
20. Gautam JK, Parashar D, Dewasi G, R T, Gibi J, Anand PK, et al. Community and health system challenges in oral cancer screening in India: a systematic review. BMC Oral Health. 2026. doi:10.1186/s12903-026-10216-6. ↩
21. Anand PK, Raika GR, Gautam J, Bhardwaj P. Mapping the evolution of implementation science: a bibliometric analysis of global and Indian research landscapes. Clin Epidemiol Glob Health. 2026;42:102488. doi:10.1016/j.cegh.2026.102488. ↩
22. Gautam JK, R T, Dewasi G, Parashar D, Bhardwaj P. Barriers and facilitators of oral, breast, and cervical cancer screening in India: a systematic review. BMC Public Health. 2026. doi:10.1186/s12889-026-29309-6. ↩
23. Anand PK, Patel D, Vats K, Gautam JK. Perceptions of healthcare providers in the implementation of National Tuberculosis Elimination Program guidelines at malnutrition treatment centres in Jodhpur, Rajasthan, India: a qualitative study [Preprint]. Research Square; 2026 Aug 31. doi:10.21203/rs.3.rs-10701101/v1. ↩
24. Anand PK, Banerjee P, Dewasi G, Gautam JK. Tuberculosis and associated vulnerabilities among rural residents in Jaipur District, Rajasthan, India: a community-based cross-sectional study [Preprint]. Research Square; 2026 Aug 14. doi:10.21203/rs.3.rs-10364362/v1. ↩
25. Singh J, Gazta P, Gautam JK, Bhardwaj P, Mohanty SS. Exploring barriers to healthcare access among individuals with sickle cell disease and their caregivers in the tribal areas of Rajasthan: application of socio-ecological model. BMC Public Health. 2026. doi:10.1186/s12889-026-28301-4. ↩
26. Jain R, Chouhan D, Gautam JK, Kumawat R. Temporal stability of human serum for the diagnosis of dengue virus by ELISA. Journal on Communications. 2026;21(9):1-7. ↩
27. Kaur M, Gautam JK, Sharma AR, Singh V, Chouhan D, Baghel A, et al. Nanotechnology-based detection of sickle cell disease and thalassemia: a systematic review. Biosensors (Basel). 2026;16(7):373. doi:10.3390/bios16070373. ↩
28. Dewasi G, Nagda P, Bahl G, Jain V, Gupta SK. Myostatin-driven muscle hypertrophy: a double-edged sword in muscle physiology. J Rare Dis. 2025;4:29. doi:10.1007/s44162-025-00086-x. ↩
29. Halder C, Dewasi G, Nagda P. From fibroadenomas to phyllodes: unraveling the spectrum and clinical profile of benign breast diseases. Curr Trends Med Clin Res. 2025;1(1). doi:10.5281/zenodo.16986117. ↩
30. Pareek A, Kanwar P, Bansal R, Maheshwari B, Joshi A, Dewasi G, et al. Surgeon-in-the-loop AI systems in robotic surgery: enhancing precision, efficiency, and personalization: a short narrative review. Curr Trends Med Clin Res. 2025;1(1). doi:10.5281/zenodo.16947522. ↩
31. Dewasi G, Jain S, Saraf M, Vaghela JS. Evaluation of preemptive single dose of pregabalin for postoperative pain control after laparoscopic cholecystectomy: a prospective comparative study from western India. Dolor. 2026;41(2):31-37. doi:10.24875/DOL.M25000032. ↩
32. Tanwar CS, Jain V, Nagda P, Ramani K, Bahl G, Dewasi G, et al. A rare presentation of chronic lower back ache radiating to lower limb in a patient with ankylosing spondylitis with Andersson lesion managed by methotrexate: a case report [Preprint]. Research Square. 2025 May 13. doi:10.21203/rs.3.rs-6459382/v1. ↩
33. Dewasi G. Possible role of thyroid in epilepsy. J Sci Res Technol. 2023;1(6):44-47. doi:10.5281/zenodo.8308519. ↩
34. Nagda P, Rathore UBS, Dewasi G. Systemic light-chain amyloidosis: evolving diagnostic paradigms and emerging therapeutic strategies beyond ANDROMEDA. Curr Trends Med Clin Res. 2026;5(4). doi:10.5281/zenodo.23790867. ↩
35. Nagda P, Dewasi G, Jain S, Godara R. Why Southern Rajasthan needs an ICMR centre: a case for Udaipur, Salumbar and Pratapgarh. Curr Trends Med Clin Res. 2026;5(4). doi:10.5281/zenodo.23791067. ↩
36. Nagda P, Dewasi G, Jain S. The case for an ICMR centre in Southern Rajasthan: a review with focus on Udaipur, Salumbar and Pratapgarh. Curr Trends Med Clin Res. 2026;5(4). doi:10.5281/zenodo.23791206. ↩
37. Dewasi G, Jain S. Ferroptosis in cancer: molecular mechanisms, tumour microenvironment, therapeutic resistance, and clinical translation. J Egypt Natl Canc Inst. 2026;38(1):80. doi:10.1186/s43046-026-00419-x. ↩
38. Dewasi G, Nagda P, Jain S, Soni S. Pre-operative single 150 mg dose of pregabalin for postoperative pain management in laparoscopic cholecystectomy: a systematic review and meta-analysis [Preprint]. medRxiv. 2026 Jul 13. doi:10.64898/2026.07.11.26357848. ↩